Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,958 total articles
ALX Oncology Holdings Inc., a clinical-stage biotechnology company, announced that its Compensation Committee approved an inducement stock option grant of 800,000 shares to Jeff Knight, the newly appointed Chief Development and Operating Officer, as per Nasdaq Listing Rule 5635(c)(4). The stock options have an exercise price equal to the closing st…
Zhihu Inc., a leading online content community in China, has filed its annual report for the fiscal year ended December 31, 2025, on Form 20-F with the U.S. Securities and Exchange Commission. The report includes audited consolidated financial statements and is accessible on the company’s investor relations website. Zhihu offers free hard copies to…
Revolution Medicines, a Nasdaq-listed late-stage clinical oncology company specializing in RAS-addicted cancer therapies, completed concurrent upsized public offerings of common stock and convertible senior notes totaling approximately $2.2 billion. The net proceeds will be utilized to support research and development, potential commercialization, …
Hingham Institution for Savings reported first quarter 2026 earnings showing a 60.2% decrease in GAAP net income per share compared to last year, primarily due to a net loss on equity securities. However, Core net income, excluding equity securities gains/losses, rose 72.3%. Total assets grew slightly to $4.55 billion with retail and commercial dep…
Olema Oncology announced compelling preclinical data for its breast cancer therapies palazestrant and OP-3136 at the 2026 AACR Annual Meeting. Palazestrant, a complete estrogen receptor antagonist and degrader, demonstrated robust anti-tumor activity by recruiting corepressor NCoR1 to fully block estrogen receptor activity. Combined with OP-3136, a…
New Era Energy & Digital, Inc. announced the appointment of Andy Casazza as Chief Corporate Officer effective April 28, 2026. Casazza brings extensive experience from the energy sector to support the company’s strategy, capital planning, governance, and execution, particularly in advancing its Texas Critical Data Centers project and related growth …
Cardiff Oncology presented preclinical data demonstrating that its oral PLK1 inhibitor, onvansertib, combined with trastuzumab deruxtecan (T-DXd), a HER2-targeted antibody-drug conjugate, shows robust antitumor activity and overcomes resistance in HER2-low breast cancer models. The combination produced high tumor regression rates and good tolerabil…
Xilio Therapeutics announced new preclinical data for XTX601, a masked T cell engager aimed at selectively targeting the tumor-associated antigen CLDN18.2 in gastric, pancreatic, and esophageal cancers. The data demonstrated tumor-selective activation, potent anti-tumor activity in multiple models, and a favorable safety profile in non-human primat…
Acrivon Therapeutics announced preclinical findings demonstrating strong synergistic effects of its lead cancer drug candidates ACR-368 and ACR-2316 when combined with anti-PD-L1 immune checkpoint inhibitors and antibody-drug conjugate (ADC) payloads, specifically Topoisomerase 1 inhibitors. These results support the potential for developing frontl…
Zhihu Inc., a leading Chinese online content community listed on NYSE (ZH) and HKEX (2390), has published its 2025 Environmental, Social, and Governance Report. The Report details Zhihu's sustainability efforts, corporate culture development, and commitment to creating long-term value for stakeholders. The document is accessible in both English and…
Repligen Corporation has inaugurated its third global Training & Innovation Center in Breda, Netherlands, expanding its global customer support network. The new center at the OPUS pre-packed chromatography columns manufacturing facility offers hands-on experiences with Repligen's diverse bioprocessing technologies. This expansion complements existi…
Medicus Pharma Ltd. has submitted an Orphan Drug Designation application to the FDA for SkinJect®, a localized treatment for basal cell carcinoma in patients with Gorlin Syndrome, a rare genetic disorder causing frequent skin cancers. The move targets a high unmet medical need with no approved therapies, aiming to offer a repeatable, non-surgical o…
PMGC Holdings, Inc. announced a $40 million equity purchase facility agreement with an institutional investor, providing flexible capital to support its roll-up strategy targeting U.S.-based precision manufacturing companies in aerospace, defense, and industrial sectors. The company aims to grow through acquisitions and operational investments, cap…
Lincoln Educational Services Corporation announced the date and details for its first quarter 2026 earnings release and conference call, scheduled for May 11, 2026. The company will provide a webcast and teleconference access to discuss its financial results and business updates. Lincoln is a leading provider of career-oriented post-secondary educa…
BGIN BLOCKCHAIN LIMITED, a Nasdaq-listed digital asset technology company specializing in proprietary cryptocurrency mining technologies and hardware manufacturing, announced the date and details of its Fiscal Year 2025 earnings conference call to be held on April 24, 2026. Management will discuss financial results and strategic developments relati…
CTW Cayman announced an Annual General Meeting to be held on May 7, 2026, where shareholders will vote on proposals including changing the corporate name to CTW, adopting the second amended and restated memorandum and articles of association, and related actions. The Board recommends shareholders vote in favor of all proposals. CTW operates a leadi…
Zenas BioPharma announced the grant of 41,475 restricted stock units to newly hired employees as an inducement to join the company, vesting over four years. The grants are given under Nasdaq Listing Rule 5635(c)(4) and relate to Zenas' ongoing efforts to build its workforce as it advances its clinical-stage autoimmune disease therapies.
Alterity Therapeutics has appointed Ann Cunningham, a seasoned biotech and pharmaceutical executive with over 25 years' experience, to its Board of Directors. This strategic move comes as the company prepares to advance its lead candidate ATH434 into Phase 3 trials for Multiple System Atrophy (MSA), highlighting confidence in its late-stage develop…
Celularity Inc., a regenerative and cellular medicine company, announced receipt of a notice from Nasdaq for not timely filing its Annual Report on Form 10-K for fiscal year 2025. The company is working to complete and file the report soon and has 60 days to submit a plan to regain compliance. Nasdaq may grant an extension if the plan is accepted. …
Sysco Corporation's Board of Directors declared a quarterly cash dividend increase of $0.01 to $0.55 per share, payable July 24, 2026. This dividend raise highlights Sysco's strong shareholder return strategy and its status as a Dividend Aristocrat. The company plans a total annual dividend increase of $0.04 for fiscal year 2027, reinforcing its ba…
Smithfield Foods, a leading American packaged meats and fresh pork company, announced the formation of an integrated agency team including Leo Chicago, LaForce, Kelly Scott Madison Media, and Mars United Commerce. This strategic partnership aims to accelerate market presence, deepen consumer connections, and drive product innovation across its dive…
Lyra Therapeutics announced its intention to voluntarily file Form 25 to delist its common stock from Nasdaq following suspension of trading in March 2026. The company plans to deregister its stock by filing Form 15 to terminate reporting obligations with the SEC, continuing its shares' quotation on the Pink Limited Market.
Commerce (NASDAQ: CMRC), the parent company of BigCommerce and Feedonomics, announced winners of its 2026 EMEA Customer and Partner Awards recognizing outstanding innovation, growth, and digital transformation achievements. The awards highlight significant advancements in AI-driven commerce, connected customer experiences, and B2B ecommerce excelle…
zSpace, Inc., a Nasdaq-listed AR/VR solutions provider for education and workforce development, announced a 1-for-25 reverse stock split to increase its per-share stock price and regain compliance with Nasdaq's minimum bid price rule. The split will reduce outstanding shares from approximately 76 million to 3 million, with trading on Nasdaq continu…
Lexicon Pharmaceuticals announced the presentation of additional Phase 2b study data (PROGRESS) on pilavapadin, supporting the selection of the 10 mg dose for Phase 3 development in diabetic peripheral neuropathic pain (DPNP). The data demonstrate a nominally significant reduction in average pain with good tolerability. The company also shared prec…
